Tag: Astellas Pharma

Astellas Pharma to acquire US gene therapy company Audentes Therapeutics

pharmanewsdaily- December 8, 2019

Astellas acquisition of Audentes: Japanese pharma company Astellas Pharma has agreed to acquire US gene therapy company Audentes Therapeutics in an all-cash deal worth about ... Read More

Pandion bags $795m deal with Astellas for pancreas-targeted immunomodulators

pharmanewsdaily- November 2, 2019

Pandion Therapeutics has bagged a $795 million worth license and collaboration deal with Japanese pharma company Astellas Pharma for the research, development, and commercialization of ... Read More

Japanese pharma company Astellas acquires Potenza Therapeutics

pharmanewsdaily- December 16, 2018

Astellas acquisition of Potenza : Japanese pharma company Astellas Pharma has exercised an option to acquire US-based Potenza Therapeutics in a deal worth up to ... Read More

Astellas, Pfizer score Xtandi FDA approval for non-metastatic CRPC

pharmanewsdaily- July 14, 2018

Xtandi FDA approval : Astellas Pharma and Pfizer said that the US Food and Drug Administration (FDA) has expanded the approval of cancer drug Xtandi ... Read More